Latest Trials
| EudraCT Number: 2004-004681-33 | Sponsor Protocol Number: D1447C00001 | Start Date: 2005-04-15 | ||||||
| Sponsor Name: AstraZeneca AB | ||||||||
| Full Title: An International, Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase III study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel™, single oral 300 mg or 600... | ||||||||
| Medical condition: Bipolar Depression | ||||||||
|
||||||||
| Population Age: Adults | Gender: Male, Female | |||||||
| Trial protocol: LT (Completed) LV (Completed) EE (Completed) DE (Completed) | ||||||||
| Trial results: View results | ||||||||